The CMS said 24.2 million people signed up during the enrollment window, including 3.9 million new enrollees. That's more than double the number of people who enrolled during the 2021 sign-up period, according to the announcement.

The Centers for Medicare & Medicaid Services on Friday released an informational bulletin with updated federal poverty level standards applied to eligibility criteria for Medicaid.

The newly installed Trump administration late Tuesday prompted federal health agencies, including the Centers for Medicare & Medicaid Services (CMS),

The U.S. health agency, the Centers for Medicare & Medicaid Services (CMS), announced Tuesday that it will appeal a November 2024 ruling to the Fifth Circuit Court of Appeals. What Happened: In October,

The CMS administrator highlighted her agency’s efforts to help states fast-track Medicaid renewals — and warned of walking back expansion.

Federal health agencies, including the Centers for Medicare & Medicaid Services, have halted their communication efforts in the first days of the Trump administration.

The feds intend to appeal a judge's decision that would force them to recalculate UnitedHealthcare's Medicare Advantage (MA) star ratings. | The feds intend to appeal a judge's decision that would force them to recalculate UnitedHealthcare's Medicare Advantage star ratings.

The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started, so current drug prices are unaffected.

Providers are required by federal law to return Medicare and Medicaid overpayments within 60 days of identifying the overpayment or they can be

CMS has been dedicated to strengthening Medicaid and CHIP by helping eligible people more easily enroll and keep their coverage; expanding Medicaid to more Americans; investing in children’s health; strengthening mental health,

In November, a federal judge ordered CMS to recalculate UnitedHealthcare's Medicare Advantage Star Ratings for the 2025 plan year.

The Centers for Medicare and Medicaid Services (CMS) has included Ozempic among the next 15 drugs chosen for Medicare negotiation. The CMS listed Ozempic, Rybelsus and Wegovy — all forms of